Ivim Health vs MEDVi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Ivim Health scores higher on our rubric, 7.9/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MEDVi - $179 first month, then $299/mo →or find your match

Ivim Health beats MEDVi overall, scoring 7.9/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Ivim Health is from $150/mo; MEDVi is $179 first month, then $299/mo. Choose Ivim Health for users who want personalized dosing with frequent provider check-ins. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program.

A side-by-side look at Ivim Health and MEDVi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Ivim Health

#6 of 54

7.9/10

Personalized GLP-1 program with frequent provider check-ins and customized dosing schedules at an affordable price point.

Visit Ivim Health

MEDVi

#46 of 54

5.7/10

MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.

Visit MEDVi

Feature	Ivim Health	MEDVi
Why each one	Package-based pricing with Klarna financing, commit to 6 or 12 months of medication and lock in lower effective monthly rates ($150/mo all-in for 12-month sema).	Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication.
Our Score	7.9/10	5.7/10
Headline Price	from $150/mo	$179 first month, then $299/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want personalized dosing with frequent provider check-ins	Users who want both oral and injectable compounded options in one telehealth program
Watch out for	The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses	FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
Ranking	#6	#46
Get started	Visit Ivim Health	Visit MEDVi

Pros & Cons Compared

Ivim Health

Pros

+$75/mo starting price is among the lowest in the market for a program with actual provider oversight
+Bi-weekly provider check-ins included, more frequent than most platforms at this price point
+Personalized titration schedules based on individual tolerance, not cookie-cutter dose escalation
+Both brand-name and compounded available, with the option to switch based on response

Cons

−The $75/mo starting price increases with dose, expect $150-200/mo at maintenance doses
−No insurance billing, and the cost increase at higher doses isn't always clearly communicated upfront

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping

Cons

−FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
−Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
−The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
−Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Our Verdict

Ivim Health edges out MEDVi with a score of 7.9/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: Ivim Health is from $150/mo; MEDVi is $179 first month, then $299/mo.